Document is current
Any future updates will be listed below
-
Authors
Mantuano, Paola
van Putten, Maaike
Cobb, Buket Sonbas
Putker, Kayleigh
Boccanegra, Brigida
Tanganyika-de Winter, Christa
Tulimiero, Lisamaura
Schneider, Anne-Fleur
Cappellari, Ornella
Van De Vijver, Davy
Engelbeen, Sarah
Pandeya, Sarbesh
Nagy, Janice A.
Rutkove, Seward
-
Funding
Funding for this research was provided by:
Duchenne UK (na, na)
Charlies Fund (na, na)
TUBITAK (2219-International Postdoctoral Research Fellowship Program for Turkish Citizens)
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 21 August 2025
First Online: 26 September 2025
Declarations
:
: Dr. Rutkove has equity in and serves as a consultant and scientific advisor to Myolex Inc., a company that designs impedance devices for clinical and research use and used in this study; he is also a member of Myolex’s Board of Directors. The company also has an option to license patented impedance technology of which Dr. Rutkove is named as an inventor. The other authors declare no competing interests.
